These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30106267)

  • 1. Successful treatment of psychosis in dentatorubral-pallidoluysian atrophy with quetiapine: A case report.
    Narita Z; Sumiyoshi T
    Neuropsychopharmacol Rep; 2018 Mar; 38(1):44-46. PubMed ID: 30106267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful Treatment with Olanzapine of Psychosis in Dentatorubral-pallidoluysian Atrophy: A Case Report.
    Narita Z; Sumiyoshi T
    Clin Psychopharmacol Neurosci; 2018 May; 16(2):221-223. PubMed ID: 29739138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dentatorubral-pallidoluysian atrophy (DRPLA) presenting with psychosis.
    Adachi N; Arima K; Asada T; Kato M; Minami N; Goto Yi ; Onuma T; Ikeuchi T; Tsuji S; Hayashi M; Fukutani Y
    J Neuropsychiatry Clin Neurosci; 2001; 13(2):258-60. PubMed ID: 11449034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial.
    Pagsberg AK; Jeppesen P; Klauber DG; Jensen KG; Rudå D; Stentebjerg-Olesen M; Jantzen P; Rasmussen S; Saldeen EA; Lauritsen MG; Bilenberg N; Stenstrøm AD; Nyvang L; Madsen S; Werge TM; Lange T; Gluud C; Skoog M; Winkel P; Jepsen JRM; Fagerlund B; Correll CU; Fink-Jensen A
    Lancet Psychiatry; 2017 Aug; 4(8):605-618. PubMed ID: 28599949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug-naïve patients with a first-episode of non-affective psychosis.
    Vázquez-Bourgon J; Pérez-Iglesias R; Ortiz-García de la Foz V; Suárez Pinilla P; Díaz Martínez Á; Crespo-Facorro B
    Psychopharmacology (Berl); 2018 Jan; 235(1):245-255. PubMed ID: 29075885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quetiapine for Parkinson's Disease psychosis: Evidence-based medicine versus expert belief: A case study.
    Friedman JH
    Mov Disord; 2018 Jul; 33(7):1186-1187. PubMed ID: 29644756
    [No Abstract]   [Full Text] [Related]  

  • 7. The Added Value of Liquid Antipsychotics: The Case of Quetiapine.
    Papazisis G; Siafis S
    Curr Clin Pharmacol; 2019; 14(2):101-107. PubMed ID: 30387400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological interventions for psychosis in Parkinson's disease patients.
    Friedman JH
    Expert Opin Pharmacother; 2018 Apr; 19(5):499-505. PubMed ID: 29494265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson's disease and dementia with Lewy bodies.
    Horn S; Richardson H; Xie SX; Weintraub D; Dahodwala N
    Parkinsonism Relat Disord; 2019 Dec; 69():119-124. PubMed ID: 31751863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's disease psychosis management: an evidence based, experience informed, pragmatic approach.
    Friedman JH
    Expert Opin Pharmacother; 2024 Feb; 25(2):149-156. PubMed ID: 38344806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole: 12-Week Results From the Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis (TEA) Trial.
    Jensen KG; Correll CU; Rudå D; Klauber DG; Decara MS; Fagerlund B; Jepsen JRM; Eriksson F; Fink-Jensen A; Pagsberg AK
    J Am Acad Child Adolesc Psychiatry; 2019 Nov; 58(11):1062-1078. PubMed ID: 30858012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corneal endothelial degeneration in dentatorubral-pallidoluysian atrophy.
    Ito D; Yamada M; Kawai M; Usui T; Hamada J; Fukuuchi Y
    Arch Neurol; 2002 Feb; 59(2):289-91. PubMed ID: 11843701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine.
    Moreno GM; Gandhi R; Lessig SL; Wright B; Litvan I; Nahab FB
    Neurology; 2018 Oct; 91(17):797-799. PubMed ID: 30258020
    [No Abstract]   [Full Text] [Related]  

  • 14. Quetiapine for Psychosis in Parkinson Disease and Neurodegenerative Parkinsonian Disorders: A Systematic Review.
    Desmarais P; Massoud F; Filion J; Nguyen QD; Bajsarowicz P
    J Geriatr Psychiatry Neurol; 2016 Jul; 29(4):227-36. PubMed ID: 27056066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dentatorubral-pallidoluysian atrophy (DRPLA) with a small ganglioglioma component containing neurofibrillary tangles and polyglutamine aggregation.
    Yamada S; Yamazaki T; Nakata S; Nobusawa S; Ikota H; Ide M; Mizushima K; Harigaya Y; Hirato J; Yokoo H
    Neuropathology; 2017 Aug; 37(4):335-340. PubMed ID: 28144989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dentatorubral-pallidoluysian atrophy (DRPLA): The 50th Anniversary of Japanese Society of Neuropathology.
    Yamada M
    Neuropathology; 2010 Oct; 30(5):453-7. PubMed ID: 20500452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis.
    Wilby KJ; Johnson EG; Johnson HE; Ensom MHH
    Ann Pharmacother; 2017 Aug; 51(8):682-695. PubMed ID: 28385039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Improvement of action myoclonus in a patient with dentatorubral-pallidoluysian atrophy by piracetam].
    Hirose M; Yokoyama H; Noguchi R; Haginoya K; Aoki M; Iinuma K
    No To Hattatsu; 2004 Jan; 36(1):75-9. PubMed ID: 14737869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapidly progressive sporadic dentatorubral pallidoluysian atrophy with intracytoplasmic inclusions and no CAG repeat expansion.
    Espay AJ; Bergeron C; Chen R; Lang AE
    Mov Disord; 2006 Dec; 21(12):2251-4. PubMed ID: 17078058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine in the management of psychosis secondary to huntington's disease: a case report.
    Seitz DP; Millson RC
    Can J Psychiatry; 2004 Jun; 49(6):413. PubMed ID: 15283541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.